News | News By Subject | News by Disease News By Date | Search News

Ophthalmics (misc) News Articles

Get Our FREE
Industry eNewsletter
Top Breaking News
Novartis AG (NVS) and Google (GOOG)’s Verily Miss Smart Contact Lens Human Trial Goal     11/22/2016
SoCal's Aerie (AERI) Stock Soars Over the Rainbow on Positive Phase III Eye Drug Data     9/16/2016
Primary Endpoint Met in pSivida (PSDV)’s First Medidur Phase III     8/16/2016
Spark Therapeutics (ONCE) Touts Long-Term Positive Phase III Gene Therapy Data     8/11/2016
FDA Spurns Ocular Therapeutix (OCUL)'s Post-Operative Eye Pain Treatment     7/25/2016
FDA Rejects Valeant (VRX) Glaucoma Drug, Raises Concerns Over Manufacturing Issues     7/22/2016
Shire (SHPG) Soars After the FDA Approves Long-Awaited Dry-Eye Disease Drug     7/12/2016
Google (GOOG)'s DeepMind Tries to Spot Eye Conditions with Artificial Intelligence     7/5/2016
Shire (SHPG)'s Retinopathy Treatment Fails to Meet Primary Endpoint in Phase II     7/1/2016
Amid Insider Trader Investigations, Acucela (AUCL) and Otsuka Pharma Kill Glaucoma Drug Deal After Failed Trial     6/14/2016
Once Floated as Allergan (AGN) Target, Revance (RVNC)'s Stock Drops as Crow’s Feet Drug Fails Trial     6/14/2016
Noveome Debuts with Top-Line Data from Three Phase I Clinical Trials     4/13/2016
Regeneron (REGN), Bayer (BAY) Partner Up to Develop Novel Combo Therapy for Eye Diseases     3/24/2016
Embattled Bay Area XOMA  (XOMA) Terminates Gevokizumab Trials     3/14/2016
Aldeyra Therapeutics (ALDX)'s Eye Drug Effective in Phase IIa Study     2/29/2016

News from Around the Web
Breakthrough Technique Sheds New Light On Corneal Blindness, University of Melbourne Study     12/20/2016
Glasses For Just $1? That Bargain Is Helping To Solve The World's Poor Eyesight     12/15/2016
An Audacious Vision: Researchers Aim For First Human Eye Transplant Within The Decade     11/23/2016
Novartis AG (NVS) Is Gearing Up For A Huge Makeover     11/17/2016
Innovative Approaches In Ocular Drug Delivery     11/14/2016
Pixium Vision's Iris II Brings Back Sight To Blind For First Time     11/10/2016
On Front Lines Of Price Dispute, Eye Doctors Wary Of New Drug Data     11/2/2016
Smoking Pot May Give You Better Night Vision     11/1/2016
Endomag, European Device Makers Eye U.S. Amid Regulatory Changes     10/27/2016
An Online Vision-Test Startup Is Suing For The Right To Operate, Opternative Reveals     10/21/2016
Scleral Implants Improve Presbyopia Out To 3 Years     10/20/2016
University of Houston Researchers Develop Glucose-Sensing Contact Lens     10/6/2016
World’s First Robotic Eye Surgery Is A Milestone For Biomedical Tech     9/27/2016
Diabetic Macular Edema: Dexamethasone Implant May Improve Vision, IRCCS Study     9/27/2016
Israeli Researcher Invents Devices Allowing Blind People To "See" Via Vibrations, Sounds, Hebrew University of Jerusalem Study     9/16/2016

Press Releases
Pixium Vision Release: Company Achieves Implantation Of 10 Patients In Its Clinical Trial With Its Innovative 150 Electrodes IRIS II Bionic Vision System     1/12/2017
IACTA Pharma Release: Pharma Licenses NM133 From Nanomerics For Treatment Of Dry Eye     1/11/2017
Pixium Vision Release: Company Achieves Implantation Of 10 Patients In Its Clinical Trial With Its Innovative 150 Electrodes IRIS II Bionic Vision System     1/11/2017
ThromboGenics NV (TBGNF) Release: Pharma Enrolls First Patients In Phase II Clinical Study Evaluating THR-317 (Anti-PlGF) For Diabetic Macular Edema (DME)     1/10/2017
Valeant (VRX) Release: Bausch & Lomb Launches Expanded Parameters For For Presbyopia Contact Lenses     1/10/2017
Okogen Secures Ora To Conduct Clinical And Regulatory Development Of OKG-0301 For Adenoviral Conjunctivitis     1/6/2017
Xigen S.A.’s Brimapitide, An Innovative JNK Inhibitor, Delivers Positive Phase II Results In Inflammatory Eye Disease     1/5/2017
4D Molecular Therapeutics Enrolls First Patient In Natural History Study In Lead Clinical Program To Develop Gene Therapy Treatment For Choroideremia     1/5/2017
touchOPHTHALMOLOGY Release: New Review Of Clinical Research Of Ultrasound Ciliary Plasty And Implications For Clinical Practice     1/5/2017
Sun Pharma (SUNPHARMA.NS) Announces Positive Topline Results Of Confirmatory Phase-3 Clinical Trial For Seciera For Treatment Of Dry Eye     1/4/2017
Ocular Therapeutix (OCUL) Jumps on More Positive Study Data for Dextenza     1/4/2017
Nikon Corporation (NINOF.PK), Google (GOOG)'s Verily Forge Deal for Machine Learning in Retinal Imaging     1/3/2017
Another Delay, Aerie (AERI) Now Expects to Resubmit Rhopressa NDA Filing in Q1 2017     12/27/2016
MeiraGTx Granted Orphan Drug Designation For Its A004 Gene Therapy Treatment For Retinitis Pigmentosa     12/20/2016
FDA Orphan Drug Designation Granted To Profounda For The Treatment Of Acanthamoeba Keratitis With Miltefosine     12/19/2016